Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDVN > SEC Filings for MDVN > Form 8-K on 10-Feb-2014All Recent SEC Filings

Show all filings for MEDIVATION, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MEDIVATION, INC.


10-Feb-2014

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

2013 Bonuses

On February 4, 2014, the Compensation Committee of the Board of Directors (the "Committee") of Medivation, Inc. (the "Company") approved cash bonuses for the Company's executive officers pursuant to the Company's 2013 Bonus Plan, in recognition of both the level of the Company's achievement of its corporate goals for 2013 and each named executive officer's contributions toward the achievement of those goals. The bonuses awarded to the named executive officers are set forth in Exhibit 10.1 hereto and are incorporated herein by reference.

2014 Salaries

On February 4, 2014, the Committee approved new base salaries, effective January 1, 2014, for the Company's named executive officers in the amounts set forth in Exhibit 10.1 hereto, which is incorporated herein by reference.

2014 Target Bonuses

On February 4, 2014, the Committee approved 2014 target bonuses for the Company's named executive officers, which bonuses are set forth in Exhibit 10.2 hereto and is incorporated herein by reference. The actual bonuses will be paid depending upon Company performance in accordance with the 2014 Bonus Plan, which has not yet been established.

Equity Awards

On February 4, 2014, the Committee approved the grant of stock options and restricted stock units ("RSUs") under the Company's Amended and Restated 2004 Equity Incentive Award Plan (the "2004 Plan") to the Company's Chief Executive Officer and other named executive officers, other than C. Patrick Machado, the Company's Chief Business Officer and Chief Financial Officer, who will be retiring from the Company as previously announced and so did not receive any equity awards. The number of shares of the Company's common stock underlying the grants is set forth in the table below:

                               Number of Shares of           Number of Shares of
                             Common Stock Underlying       Common Stock Underlying
  Named Executive Officer         Stock Options            Restricted Stock Units
  David Hung, M.D.                            133,000                        25,000
  President and Chief
  Executive Officer
  Cheryl Cohen                                 39,000                         7,000
  Chief Commercial
  Officer
  Lynn Seely, M.D.                             39,000                         7,000
  Chief Medical Officer

The grant date of the stock options, determined in accordance with the Company's Stock Option Grant Date Policy, will be February 17, 2014. One-fourth of the shares subject to the stock


options will vest and become exercisable on the first anniversary of the grant date, and the remaining three-fourths of the shares will vest monthly over the three years thereafter, subject to continued service. The stock options will have an exercise price equal to the fair market value per share of the Company's common stock on the grant date, as determined in accordance with the terms of the 2004 Plan, and a term of 10 years from the grant date.

The grant date of the RSUs was February 4, 2014. The RSUs will vest annually over three years beginning on February 4, 2014, subject to continued service.

The description of the stock options contained herein is a summary of their material terms, does not purport to be complete and is qualified in its entirety by reference to the Stock Option Grant Notice and Stock Option Agreement for use in connection with the grant of the Options, which were filed with the Company's Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on February 11, 2005, and incorporated herein by reference to this Current Report on Form 8-K.

The description of the RSUs contained herein is a summary of their material terms, does not purport to be complete and is qualified in its entirety by reference to the Restricted Stock Unit Grant Notice and Agreement for use in connection with the grant of the restricted stock units, which was filed with the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 28, 2012, and incorporated herein by reference to this Current Report on Form 8-K.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
No. Description

10.1 2013 Bonuses and 2014 Base Salaries for Named Executive Officers.

10.2 2014 Target Bonuses for Named Executive Officers.


  Add MDVN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDVN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.